SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-10-235614
Filing Date
2010-10-25
Accepted
2010-10-25 16:35:54
Documents
2
Period of Report
2010-10-01
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K AMENDMENT d8ka.htm 8-K/A 20147
2 LETTER FROM STONEFIELD JOSEPHSON, INC. TO THE SECURITIES AND EXCHANGE COMMISSION dex161.htm EX-16.1 1862
  Complete submission text file 0001193125-10-235614.txt   23546
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-12465 | Film No.: 101140181
SIC: 2834 Pharmaceutical Preparations